Total Holdings
50
Portfolio diversification across 50 positions
GNOM
(NASDAQ)Global X Genomics & Biotechnology ETF
$46.32-- (--)
Loading... - Market loading
GNOM ETF Holdings: Global X Genomics & Biotechnology ETF
Complete portfolio holdings with allocation weights, sector breakdown, and geographic exposure for this Equity ETF. Analyze fund diversification and concentration.
Assets Under Management
$52.54M
Total fund assets
Expense Ratio
0.50%
Annual management fee
Fund Issuer
Global X
NASDAQ
Portfolio Allocations
Distribution breakdown by sector, asset type, and geographic region. Understand the fund's diversification strategy across markets and asset classes.
Loading chart...
Top 50 Holdings by Portfolio Weight
View ticker symbols, company names, asset types, and allocation percentages for each position
Scroll to see more
| # | Symbol | Name | Type | Weight |
|---|---|---|---|---|
| 1 |  | Arrowhead Pharmaceuticals, Inc | Stock | 6.51% |
| 2 |  | Moderna, Inc. | Stock | 6.33% |
| 3 |  | Praxis Precision Medicines, Inc. | Stock | 5.98% |
| 4 |  | Guardant Health, Inc | Stock | 5.69% |
| 5 |  | Illumina, Inc. | Stock | 5.38% |
| 6 |  | Natera, Inc | Stock | 4.30% |
| 7 |  | BioMarin Pharmaceutical Inc. | Stock | 4.22% |
| 8 |  | Vertex Pharmaceuticals Incorporated | Stock | 4.21% |
| 9 |  | Bio-Techne Corporation | Stock | 4.07% |
| 10 |  | Avidity Biosciences, Inc. | Stock | 4.00% |
| 11 |  | Qiagen N.V. | Stock | 3.95% |
| 12 |  | BioNTech SE | Stock | 3.91% |
| 13 | E ETR:QIA | QIAGEN N.V | Stock | 3.80% |
| 14 |  | CRISPR Therapeutics AG | Stock | 3.02% |
| 15 |  | Bristol-Myers Squibb Company | Stock | 2.67% |
| 16 |  | Alnylam Pharmaceuticals, Inc | Stock | 2.66% |
| 17 |  | Veracyte, Inc | Stock | 2.47% |
| 18 |  | Twist Bioscience Corporation | Stock | 2.44% |
| 19 |  | Gilead Sciences, Inc. | Stock | 2.41% |
| 20 |  | Eli Lilly and Company | Stock | 2.40% |
| 21 | L LON:AZN | AstraZeneca PLC | Stock | 2.18% |
| 22 |  | Beam Therapeutics Inc | Stock | 2.17% |
| 23 | L LSE:AZN | AstraZeneca PLC | Stock | 2.07% |
| 24 |  | GeneDx Holdings Corp. | Stock | 2.06% |
| 25 |  | Legend Biotech Corporation | Stock | 1.99% |
| 26 |  | Ultragenyx Pharmaceutical Inc. | Stock | 1.91% |
| 27 |  | 10x Genomics, Inc | Stock | 1.82% |
| 28 |  | Sarepta Therapeutics, Inc | Stock | 1.59% |
| 29 | H HKG:1548 | Genscript Biotech Corp | Stock | 1.52% |
| 30 |  | Wave Life Sciences Ltd | Stock | 1.48% |
| 31 |  | uniQure N.V | Stock | 1.29% |
| 32 |  | Intellia Therapeutics, Inc | Stock | 1.13% |
| 33 |  | CareDx, Inc | Stock | 0.88% |
| 34 |  | Vir Biotechnology, Inc | Stock | 0.59% |
| 35 |  | Pacific Biosciences of California, Inc | Stock | 0.47% |
| 36 |  | Fulgent Genetics, Inc | Stock | 0.44% |
| 37 |  | REGENXBIO Inc | Stock | 0.43% |
| 38 |  | Agilent Technologies, Inc | Stock | 0.42% |
| 39 |  | Personalis, Inc | Stock | 0.42% |
| 40 |  | Myriad Genetics, Inc | Stock | 0.40% |
| 41 |  | Mesa Laboratories, Inc | Stock | 0.31% |
| 42 | F FLDM | Fluidigm Corporation | Stock | 0.31% |
| 43 |  | Prime Medicine Inc. Common Stock | Stock | 0.30% |
| 44 |  | Stoke Therapeutics, Inc | Stock | 0.29% |
| 45 |  | Maravai LifeSciences Holdings, Inc | Stock | 0.29% |
| 46 |  | Rocket Pharmaceuticals Inc | Stock | 0.25% |
| 47 |  | Sana Biotechnology, Inc | Stock | 0.22% |
| 48 |  | Arcturus Therapeutics Holdings Inc | Stock | 0.21% |
| 49 |  | Editas Medicine, Inc | Stock | 0.18% |
| 50 |  | Sangamo Therapeutics, Inc | Stock | 0.18% |